Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.

Malik-Soni N, Frappier L.

J Virol. 2012 Jun;86(12):6999-7002. doi: 10.1128/JVI.00194-12. Epub 2012 Apr 11. Erratum in: J Virol. 2015 Sep;89(17):9143.

2.

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.

Dheekollu J, Malecka K, Wiedmer A, Delecluse HJ, Chiang AK, Altieri DC, Messick TE, Lieberman PM.

Oncotarget. 2017 Jan 31;8(5):7248-7264. doi: 10.18632/oncotarget.14540.

3.

EBNA1.

Frappier L.

Curr Top Microbiol Immunol. 2015;391:3-34. doi: 10.1007/978-3-319-22834-1_1. Review.

PMID:
26428370
4.

Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus.

Westhoff Smith D, Sugden B.

Viruses. 2013 Jan 16;5(1):226-40. doi: 10.3390/v5010226. Review.

5.

Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.

Sivachandran N, Sarkari F, Frappier L.

PLoS Pathog. 2008 Oct 3;4(10):e1000170. doi: 10.1371/journal.ppat.1000170.

6.

Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.

Sivachandran N, Dawson CW, Young LS, Liu FF, Middeldorp J, Frappier L.

J Virol. 2012 Jan;86(1):60-8. doi: 10.1128/JVI.05623-11. Epub 2011 Oct 19.

7.

Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein.

Malik-Soni N, Frappier L.

J Virol. 2014 Feb;88(4):2323-6. doi: 10.1128/JVI.02521-13. Epub 2013 Nov 27.

8.

Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.

Pisano G, Roy A, Ahmed Ansari M, Kumar B, Chikoti L, Chandran B.

Virol J. 2017 Nov 13;14(1):221. doi: 10.1186/s12985-017-0891-5.

9.

Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.

Mansouri S, Pan Q, Blencowe BJ, Claycomb JM, Frappier L.

J Virol. 2014 Oct;88(19):11166-77. doi: 10.1128/JVI.01785-14. Epub 2014 Jul 16.

10.

Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.

Tempera I, De Leo A, Kossenkov AV, Cesaroni M, Song H, Dawany N, Showe L, Lu F, Wikramasinghe P, Lieberman PM.

J Virol. 2015 Oct 14;90(1):345-55. doi: 10.1128/JVI.02318-15. Print 2016 Jan 1.

11.

Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.

Pimienta G, Fok V, Haslip M, Nagy M, Takyar S, Steitz JA.

PLoS One. 2015 Jun 29;10(6):e0124638. doi: 10.1371/journal.pone.0124638. eCollection 2015.

12.

The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.

Liu CD, Chen YL, Min YL, Zhao B, Cheng CP, Kang MS, Chiu SJ, Kieff E, Peng CW.

PLoS Pathog. 2012;8(12):e1003084. doi: 10.1371/journal.ppat.1003084. Epub 2012 Dec 13.

13.

Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.

Kalla M, Hammerschmidt W.

Eur J Cell Biol. 2012 Jan;91(1):65-9. doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29. Review.

PMID:
21450364
14.

Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.

Kariya Y, Hamatake M, Urano E, Yoshiyama H, Shimizu N, Komano J.

Cancer Sci. 2010 Apr;101(4):876-81. doi: 10.1111/j.1349-7006.2009.01474.x. Epub 2009 Dec 16.

15.
16.

Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.

Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K.

J Med Virol. 2003 Jul;70(3):410-9.

PMID:
12767005
17.

A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer.

Oh ST, Seo JS, Moon UY, Kang KH, Shin DJ, Yoon SK, Kim WH, Park JG, Lee SK.

Virology. 2004 Mar 15;320(2):330-6.

18.

In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.

Daikoku T, Kudoh A, Fujita M, Sugaya Y, Isomura H, Tsurumi T.

J Biol Chem. 2004 Dec 24;279(52):54817-25. Epub 2004 Oct 21.

19.

Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.

Daskalogianni C, Pyndiah S, Apcher S, Mazars A, Manoury B, Ammari N, Nylander K, Voisset C, Blondel M, Fåhraeus R.

J Pathol. 2015 Jan;235(2):334-41. doi: 10.1002/path.4431. Review.

PMID:
25186125
20.

Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.

Sivachandran N, Wang X, Frappier L.

J Virol. 2012 Jun;86(11):6146-58. doi: 10.1128/JVI.00013-12. Epub 2012 Apr 4.

Supplemental Content

Support Center